Prospera Private Wealth LLC Takes $35,000 Position in Solventum Co. (NYSE:SOLV)

Prospera Private Wealth LLC purchased a new position in shares of Solventum Co. (NYSE:SOLV) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 502 shares of the company’s stock, valued at approximately $35,000.

Other hedge funds also recently added to or reduced their stakes in the company. Copeland Capital Management LLC purchased a new position in shares of Solventum during the third quarter valued at approximately $26,000. Mather Group LLC. purchased a new position in Solventum during the 3rd quarter valued at $27,000. EverSource Wealth Advisors LLC bought a new position in Solventum in the 1st quarter valued at $30,000. Hollencrest Capital Management purchased a new stake in Solventum in the second quarter worth $25,000. Finally, Deseret Mutual Benefit Administrators bought a new stake in shares of Solventum during the second quarter worth $25,000.

Wall Street Analysts Forecast Growth

SOLV has been the topic of several recent analyst reports. BTIG Research started coverage on shares of Solventum in a research note on Thursday, September 5th. They issued a “neutral” rating on the stock. Wolfe Research started coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating for the company. Piper Sandler increased their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Stifel Nicolaus started coverage on Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 target price for the company. Finally, The Goldman Sachs Group increased their price target on Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research report on Monday, August 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $68.00.

Solventum Price Performance

SOLV opened at $70.81 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05. The stock has a fifty day moving average price of $70.53 and a 200-day moving average price of $62.35.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.